ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
5.41
+0.33 (6.50%)
At close: May 12, 2025, 4:00 PM
5.40
-0.01 (-0.18%)
After-hours: May 12, 2025, 7:18 PM EDT
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $384.59 million as of May 12, 2025. Its market cap has decreased by -29.40% in one year.
Market Cap
384.59M
Enterprise Value
189.58M
1-Year Change
-29.40%
Ranking
Category
Stock Price
$5.41
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has decreased from $741.98M to $384.59M, a decrease of -48.17%. That is a compound annual growth rate of -12.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 361.13M | -36.59% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 655.35B |
| Johnson & Johnson | 370.49B |
| UnitedHealth Group | 347.85B |
| AbbVie | 332.45B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 230.84B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |